| 0008-1123 | These highlights do not include all the information needed to use DUAVEE safely and effectively. See full prescribing information for DUAVEE. DUAVEE ® (conjugated estrogens/bazedoxifene) tablets for oral use Initial U.S. approval: 2013 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Inc | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0008-1123-12 | These highlights do not include all the information needed to use DUAVEE safely and effectively. See full prescribing information for DUAVEE. DUAVEE ® (conjugated estrogens/bazedoxifene) tablets for oral use Initial U.S. approval: 2013 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Inc | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-0749 | Premarin ® Intravenous (conjugated estrogens, USP) for injection | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-0749-05 | Premarin ® Intravenous (conjugated estrogens, USP) for injection | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-0872 | These highlights do not include all the information needed to use PREMARIN® VAGINAL CREAM safely and effectively. See full prescribing information for PREMARIN VAGINAL CREAM. PREMARIN (conjugated estrogens) vaginal cream. Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-0872-04 | These highlights do not include all the information needed to use PREMARIN® VAGINAL CREAM safely and effectively. See full prescribing information for PREMARIN VAGINAL CREAM. PREMARIN (conjugated estrogens) vaginal cream. Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-0872-21 | These highlights do not include all the information needed to use PREMARIN® VAGINAL CREAM safely and effectively. See full prescribing information for PREMARIN VAGINAL CREAM. PREMARIN (conjugated estrogens) vaginal cream. Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-0875 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0046-0975 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0046-1100 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0046-1100 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) Tablets, USP for oral use Initial U.S. Approval: 1942 | A-S Medication Solutions |
| 0046-1100 | PREMARIN ® (conjugated estrogens tablets, USP) | Aphena Pharma Solutions - Tennessee, Inc. |
| 0046-1100 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1100-52 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1100-81 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1100-91 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1101 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0046-1101 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1101-81 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1102 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1102 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0046-1102 | PREMARIN ® (conjugated estrogens tablets, USP) | State of Florida DOH Central Pharmacy |
| 0046-1102 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) Tablets, USP for oral use Initial U.S. Approval: 1942 | A-S Medication Solutions |
| 0046-1102 | PREMARIN ® (conjugated estrogens tablets, USP) | Aphena Pharma Solutions - Tennessee, Inc. |
| 0046-1102-52 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1102-81 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1102-91 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1103 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1103 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0046-1103-81 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1104 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1104 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 0046-1104-81 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1104-91 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company |
| 0046-1105 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0046-1105 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1105 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Dispensing Solutions, Inc. | PSS World Medical, Inc. |
| 0046-1105 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1105-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1105-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1106 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0046-1106 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1106 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1106-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1106-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1107 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Dispensing Solutions, Inc. | PSS World Medical, Inc. |
| 0046-1107 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1107 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1107 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Avera McKennan Hospital |
| 0046-1107 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | A-S Medication Solutions |
| 0046-1107-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1107-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1108 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1108 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1108-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1108-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-2575 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-2575 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-2575-12 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-2575-12 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-2579 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 43353-687 | PREMARIN ® (conjugated estrogens tablets, USP) | Aphena Pharma Solutions - Tennessee, Inc. |
| 43353-687-60 | PREMARIN ® (conjugated estrogens tablets, USP) | Aphena Pharma Solutions - Tennessee, Inc. |
| 43353-688 | PREMARIN ® (conjugated estrogens tablets, USP) | Aphena Pharma Solutions - Tennessee, Inc. |
| 43353-688-60 | PREMARIN ® (conjugated estrogens tablets, USP) | Aphena Pharma Solutions - Tennessee, Inc. |
| 50090-0167 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) Tablets, USP for oral use Initial U.S. Approval: 1942 | A-S Medication Solutions |
| 50090-0167-0 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) Tablets, USP for oral use Initial U.S. Approval: 1942 | A-S Medication Solutions |
| 50090-0167-5 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) Tablets, USP for oral use Initial U.S. Approval: 1942 | A-S Medication Solutions |
| 50090-0573 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | A-S Medication Solutions |
| 50090-0573-0 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | A-S Medication Solutions |
| 50090-1853 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) Tablets, USP for oral use Initial U.S. Approval: 1942 | A-S Medication Solutions |
| 50090-1853-3 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) Tablets, USP for oral use Initial U.S. Approval: 1942 | A-S Medication Solutions |
| 50742-387 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-387-01 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-387-10 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-388 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-388-01 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-388-10 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-389 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-389-01 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-389-10 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-390 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-390-01 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-390-10 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-391 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-391-01 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 50742-391-10 | These highlights do not include all the information needed to use CONJUGATED ESTROGENS TABLETS safely and effectively. See full prescribing information for CONJUGATED ESTROGENS TABLETS. CONJUGATED ESTROGENS tablets,for oral use Initial U.S. Approval: 1942 | Ingenus Pharmaceuticals, LLC | Novast Laboratories, Ltd. |
| 53808-0770 | PREMARIN ® (conjugated estrogens tablets, USP) | State of Florida DOH Central Pharmacy |
| 53808-0770-1 | PREMARIN ® (conjugated estrogens tablets, USP) | State of Florida DOH Central Pharmacy |
| 54118-7017 | Ultimate Phenolics | ABCO Labratories, Inc. |
| 54118-7017-2 | Ultimate Phenolics | ABCO Labratories, Inc. |
| 54868-0365 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-0365-0 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-0365-2 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-0365-3 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-0451 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-0451-2 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-0451-6 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-0453 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-0453-0 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-0453-2 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-0453-4 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-0453-5 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-0453-6 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-2702 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-2702-0 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-2702-1 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-3799 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 54868-3799-0 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 54868-3800 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 54868-3800-0 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 54868-4865 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-4865-0 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-4865-1 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-4865-2 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-4865-3 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-4865-4 | Physicians Total Care, Inc. DailyMed label | Physicians Total Care, Inc. |
| 54868-4866 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 54868-4866-0 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 54868-5047 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |